Evidence map›Paper›PMID 31209255›Full record

ArticleScientific reports2019

Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal.

Anita Rajamani, Kamil Borkowski, Samir Akre, Andrea Fernandez, John W Newman, Scott I Simon, Anthony G Passerini

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. The Emerging Parkinson's Disease Oxylipin-Ome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Hypertriglyceridemia: Molecular and Genetic Landscapes.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. New insight into dyslipidemia-induced cellular senescence in atherosclerosis.Biological reviews of the Cambridge Philosophical Society · 2022
    Review
  11. Review
  12. Article
  13. Observational
  14. Mechanisms of Atherosclerosis Induced by Postprandial Lipemia.Frontiers in cardiovascular medicine · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anita RajamaniDepartment of Biomedical Engineering, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA.
Kamil BorkowskiWest Coast Metabolomics Center, Genome Center, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA.
Samir AkreDepartment of Biomedical Engineering, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0003-1495-6399
Andrea FernandezDepartment of Biomedical Engineering, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA.
John W NewmanWest Coast Metabolomics Center, Genome Center, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0001-9632-6571
Scott I SimonDepartment of Biomedical Engineering, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA.
Anthony G PasseriniDepartment of Biomedical Engineering, University of California, Davis, 451 Health Sciences Dr., Davis, CA, 95616, USA. agpasserini@ucdavis.edu.
University of California, Davis · USWestern Human Nutrition Research Center · US

Funding

West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Outside-in Mechanotransduced Inflammatory TargetsR01AI047294 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SIMON, SCOTT IRWIN · 1999 to 2021
$7.0M
Vascular Mimetics to Study Inflammation and AtherosclerosisR01HL082689 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PASSERINI, ANTHONY G., SIMON, SCOTT IRWIN · 2008 to 2016
$3.2M
NHLBI NIH HHS R01 HL082689NIAID NIH HHS R01 AI047294NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

Elevated triglyceride-rich lipoproteins (TGRL) in circulation is a risk factor for atherosclerosis. TGRL from subjects consuming a high saturated fat test meal elicited a variable inflammatory response in TNFα-stimulated endothelial cells (EC) that correlated strongly with the polyunsaturated fatty acid (PUFA) content. This study investigates how the relative abundance of oxygenated metabolites of PUFA, oxylipins, is altered in TGRL postprandially, and how these changes promote endothelial inflammation. Human aortic EC were stimulated with TNFα and treated with TGRL, isolated from subjects' plasma at fasting and 3.5 hrs postprandial to a test meal high in saturated fat. Endothelial VCAM-1 surface expression stimulated by TNFα provided a readout for atherogenic inflammation. Concentrations of esterified and non-esterified fatty acids and oxylipins in TGRL were quantified by mass spectrometry. Dyslipidemic subjects produced TGRL that increased endothelial VCAM-1 expression by ≥35%, and exhibited impaired fasting lipogenesis activity and a shift in soluble epoxide hydrolase and lipoxygenase activity. Pro-atherogenic TGRL were enriched in eicosapentaenoic acid metabolites and depleted in esterified C18-PUFA-derived diols. Abundance of these metabolites was strongly predictive of VCAM-1 expression. We conclude the altered metabolism in dyslipidemic subjects produces TGRL with a unique oxylipin signature that promotes a pro-atherogenic endothelial phenotype.

Indexed as

AdultAgedCase-Control StudiesCell LineCholesterol, HDLCholesterol, LDLDietary FatsDyslipidemiasEndothelial CellsEpoxide HydrolasesFastingFatty Acids, UnsaturatedFemaleGene Expression RegulationHumansInflammationCholesterol, HDLCholesterol, LDLDietary FatsEPHX2 protein, humanEpoxide HydrolasesFatty Acids, UnsaturatedLipoproteinslipoprotein triglycerideLipoxygenaseOxylipinsTriglyceridesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1

Identifiers

PMID31209255
PMCPMC6572825
OpenAlexW2951859476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.